Skip to content
★ Sign in to follow
AV

Aberdare Ventures II, L.P.

Related company / holding
ReShape Lifesciences Inc.Anacor Pharmaceuticals, Inc.
Total declarations
17
Companies
2
▲ Purchases (12 ops.)
€3.0M
▼ Sales (0 ops.)
—

Latest filing published 01 Dec 2010 for Anacor Pharmaceuticals, Inc..

Insider track record

Disclosed buys
12
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
12

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Aberdare Ventures II, L.P.: trading record in brief

This profile gathers the share dealings of Aberdare Ventures II, L.P. across 2 companies, led by ReShape Lifesciences Inc. and Anacor Pharmaceuticals, Inc. The record holds 17 filings, for trades running from 19 May 2008 to 30 November 2010.

On the market, this insider has only ever bought: 12 purchases, €3.0M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2010 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €89k.

On 1 December 2010 came the latest disclosure, a transaction in Anacor Pharmaceuticals, Inc. The last insider purchase was made public on 1 December 2010, 5,822 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Aberdare Ventures II, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations